These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 21630282)
41. Validation of a LC/MS/MS method for the quantitation of a new gastroprokinetic agent SHR116958 and its metabolite in rat plasma. Li X; Du L; Wang C Pharmazie; 2011 Nov; 66(11):826-30. PubMed ID: 22204126 [TBL] [Abstract][Full Text] [Related]
42. Morphine brain pharmacokinetics at very low concentrations studied with accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry. Sadiq MW; Salehpour M; Forsgard N; Possnert G; Hammarlund-Udenaes M Drug Metab Dispos; 2011 Feb; 39(2):174-9. PubMed ID: 21059857 [TBL] [Abstract][Full Text] [Related]
43. Application of an ultra-performance liquid chromatography method with tandem mass spectrometry to pharmacokinetics, tissue distribution and excretion in the study of DAT-230, a novel tubulin-binding agent candidate, in rats. Tang J; Zhang C; Sun J; Zhao L; Zhang W; Liu Z; Sun L; Chen X J Pharm Biomed Anal; 2015 Jun; 110():49-57. PubMed ID: 25800882 [TBL] [Abstract][Full Text] [Related]
44. [Current status and prospects of using the prokinetic acotiamide in gastroenterology: A review]. Maev IV; Andreev DN; Zaborovsky AV; Lobanova EG Ter Arkh; 2023 Oct; 95(8):716-721. PubMed ID: 38158912 [TBL] [Abstract][Full Text] [Related]
45. Acotiamide and Functional Dyspepsia: A Systematic Review and Meta-Analysis. Shrestha DB; Budhathoki P; Subedi P; Khadka M; Karki P; Sedhai YR; Karki BR; Mir WAY Cureus; 2021 Dec; 13(12):e20532. PubMed ID: 35070565 [TBL] [Abstract][Full Text] [Related]
46. Development of a novel combination tablet containing trimebutine maleate and mosapride citrate for the treatment of functional dyspepsia. Cho KH; Choi YK; Kang JH; Choi HG; Yong CS; Park YJ Int J Pharm; 2010 Nov; 400(1-2):145-52. PubMed ID: 20826201 [TBL] [Abstract][Full Text] [Related]
47. Absorption, distribution, metabolism and excretion of [carbonyl-14C]mosapride citrate after repeated oral administration in rats. Matsumoto S; Tagawa M; Hatoyama T; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1103-8. PubMed ID: 8267677 [TBL] [Abstract][Full Text] [Related]
48. Tissue distribution and cardiac metabolism of 3-iodothyronamine. Saba A; Chiellini G; Frascarelli S; Marchini M; Ghelardoni S; Raffaelli A; Tonacchera M; Vitti P; Scanlan TS; Zucchi R Endocrinology; 2010 Oct; 151(10):5063-73. PubMed ID: 20739399 [TBL] [Abstract][Full Text] [Related]
50. Lacteal secretion, fetal and maternal tissue distribution of dasatinib in rats. He K; Lago MW; Iyer RA; Shyu WC; Humphreys WG; Christopher LJ Drug Metab Dispos; 2008 Dec; 36(12):2564-70. PubMed ID: 18787054 [TBL] [Abstract][Full Text] [Related]
51. Characterization of metabolic profile of mosapride citrate in rat and identification of two new metabolites: Mosapride N-oxide and morpholine ring-opened mosapride by UPLC-ESI-MS/MS. Sun X; Niu L; Li X; Lu X; Li F J Pharm Biomed Anal; 2009 Aug; 50(1):27-34. PubMed ID: 19362796 [TBL] [Abstract][Full Text] [Related]
52. Drug-drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338. Furuta S; Kamada E; Omata T; Sugimoto T; Kawabata Y; Yonezawa K; Wu XC; Kurimoto T Eur J Pharmacol; 2004 Aug; 497(2):223-31. PubMed ID: 15306208 [TBL] [Abstract][Full Text] [Related]
54. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals. Yoshida N; Omoya H; Kato S; Ito T Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674 [TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in rats. Sakashita M; Mizuki Y; Hashizume T; Yamaguchi T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Aug; 43(8):859-63. PubMed ID: 8216443 [TBL] [Abstract][Full Text] [Related]
56. Interspecies differences in plasma protein binding of MS-275, a novel histone deacetylase inhibitor. Acharya MR; Sparreboom A; Sausville EA; Conley BA; Doroshow JH; Venitz J; Figg WD Cancer Chemother Pharmacol; 2006 Feb; 57(3):275-81. PubMed ID: 16028097 [TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetic and bioavailability studies of 5 mg mosapride tablets in healthy Korean volunteers. Kim SH; Park YS; Kim JM; Park HJ; Lee MH; Park HK; Kim YJ; Cho SH; Shaw LM; Kang JS Int J Clin Pharmacol Ther; 2012 Jul; 50(7):524-31. PubMed ID: 22541755 [TBL] [Abstract][Full Text] [Related]
58. Profile of acotiamide in the treatment of functional dyspepsia. Ueda M; Iwasaki E; Suzuki H Clin Exp Gastroenterol; 2016; 9():83-8. PubMed ID: 27103837 [TBL] [Abstract][Full Text] [Related]
59. Central nervous system distribution kinetics of indinavir in rats. Hamidi M J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849 [TBL] [Abstract][Full Text] [Related]
60. Motilin effects on the proximal stomach in patients with functional dyspepsia and healthy volunteers. Kamerling IM; Van Haarst AD; Burggraaf J; Schoemaker RC; Biemond I; Heinzerling H; Jones R; Cohen AF; Masclee AA Am J Physiol Gastrointest Liver Physiol; 2003 May; 284(5):G776-81. PubMed ID: 12519743 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]